Kodiak Sciences Inc (KOD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.27B
Last updated: Nov 17, 2026 at 11:06 AM ET
Kodiak Sciences Inc (KOD) Stock Forecast
Analysts expect Kodiak Sciences (KOD) to earn -$3.98 per share in the fiscal year ending Dec 31, 2026. Of 7 analysts, 6 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 86% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 14.3% |
| Buy | 5 | 71.4% |
| Hold | 1 | 14.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$3.98
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$3.44
- EPS consensus, revenue $49.14M
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.98 | -$4.20 to -$3.75 | 5 | N/A | N/A | 4 |
| Dec 31, 2027 | -$3.44 | -$4.92 to -$1.99 | 4 | $49.14M | $11.26M to $164.20M | 5 |
Quarterly Estimates
The EPS consensus falls from -$1.04 for the quarter ending Dec 31, 2026 to -$1.16 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.04 | -$1.23 to -$0.93 | 7 |
| Mar 31, 2027 | -$1.16 | -$1.16 to -$1.16 | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 2 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$3.71.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.98 | -$3.98 | -$3.98 | -$3.99 | -$3.71 | N/A |
| Fiscal year ending Dec 31, 2027 | -$3.44 | -$3.44 | -$3.75 | -$3.75 | -$3.12 | N/A |
Frequently Asked Questions About KOD
What is the KOD stock forecast?
Consensus analyst estimates put Kodiak Sciences's EPS at -$3.98 for the fiscal year ending Dec 31, 2026. The consensus rating from 7 analysts is Buy.
How do analysts rate KOD stock?
Of 7 analysts covering Kodiak Sciences, 1 rates it Strong Buy, 5 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from KOD next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.98, with estimates from -$4.20 to -$3.75 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.44, with estimates from -$4.92 to -$1.99 from 4 analysts.
What revenue do analysts expect from Kodiak Sciences next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $49.14M, with estimates from $11.26M to $164.20M.
How many analysts cover KOD?
7 analysts rate Kodiak Sciences stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
KOD pages: Overview, Earnings, Forecast, Financials, Competitors